Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
What an incredibly fucking stupid headline.
Headline for Americans choking down a bucket of fried chicken with a “medical problem”.
Huh. Mine was hormonal.
Your bucket of fried chicken was hormonal?
No, I’m dying.
Wait, so not satire, then?